Biological
Fluzone High-Dose clinical trials
- studies test it
- 10
- open now
- 0
- in phase 3
- 2
- first study started
- 2006
How studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2010 | 1 |
| 2013 | 2 |
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 2
- 2
- Phase 3
- 2
- Phase 4
- 6
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 7
Sanofi Pasteur, a Sanofi Company (3) · University of Alabama at Birmingham (1) · Centers for Disease Control and Prevention (1) · Mayo Clinic (1) · Duke University (1) · Mount Sinai Hospital, Canada (1) · The University of Hong Kong (1) · Insight Therapeutics, LLC (1)
Often tested with
Tested in the same studies.
Influenza Vaccines (7) · FluBlok (1) · Fluarix (1) · Fluad vaccine (1) · Imiquimod (1)
Studies
Open first, then newest update. How each study uses Fluzone High-Dose is read from its arms, and is right about nine times in ten.
Testing it · 10
- B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older AdultsActive, not recruitingPhase 4University of Alabama at BirminghamNCT04101838Written as Fluzone High-Dose
- Immunogenicity Trial of Egg- Versus Non-Egg-Based Influenza Vaccines Among HCPCompletedPhase 4Centers for Disease Control and PreventionNCT03722589Written as Fluzone High-Dose
- Gene Signatures of Influenza Vaccine Responses in Older AdultsCompletedPhase 4Mayo ClinicNCT03603509Written as Fluzone High-Dose
- Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness PatientsStatus unknownPhase 3The University of Hong KongNCT04143451Written as Fluzone high-dose
- FLUAD® vs. Fluzone® High-Dose StudyCompletedPhase 4Duke UniversityNCT03183908Written as Fluzone® High-Dose
- A Pilot Study to Assess the Immunogenicity and Reactogenicity of High Versus Standard Dose TIVCompletedPhase 1/2Mount Sinai Hospital, CanadaNCT02263040Written as Fluzone High-Dose
- High-Dose Influenza Vaccine in Nursing HomesStatus unknownPhase 4Insight Therapeutics, LLCNCT01815268Written as HD Vaccine
- A Study of High-Dose Trivalent Inactivated Influenza Vaccine in Adults 50 to 64 Years of AgeCompletedPhase 2Sanofi Pasteur, a Sanofi CompanyNCT01258595Written as High-Dose Trivalent Inactivated Influenza Vaccine
- Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the ElderlyCompletedPhase 3Sanofi Pasteur, a Sanofi CompanyNCT00391053Written as High-Dose Inactivated, Split-Virion Influenza Vaccine
- Study of Fluzone® Quadrivalent, Fluzone® Intradermal, and Fluzone® High-Dose Influenza Virus Vaccines in AdultsCompletedPhase 4Sanofi Pasteur, a Sanofi CompanyNCT01946438Written as Fluzone® High-Dose, Influenza Virus Vaccine (2013-2014 formulation)
As the comparator · 2 — what is tested is compared with Fluzone High-Dose
- Immunogenicity, Safety, and Tolerability of a Plant-Derived Quadrivalent VLP Influenza Vaccine in Elderly AdultsCompletedPhase 2MedicagoNCT02831751Written as Fluzone® High-Dose (60 µg/strain)
- Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly SubjectsCompletedPhase 2SanofiNCT00551031Written as Split, Inactivated, Trivalent Influenza Vaccine (High-dose)